Strattera has a new bolded warning about severe liver injury
February 2005
Strattera has a new bolded warning about severe liver injury.
This is because of two new reports of extremely elevated liver enzymes...in a teen and an adult taking Strattera (atomoxetine) for attention deficit hyperactivity disorder (ADHD).
The enzymes increased several months into treatment...and normalized after stopping Strattera.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote